After terminating a two-year alliance with Canadian firm IMRO, bone densitometry vendor Norland has found a new partner for an ultrasound densitometer unit. The White Plains, NY, company in June acquired rights to distribute and service an ultrasound
After terminating a two-year alliance with Canadian firm IMRO, bone densitometry vendor Norland has found a new partner for an ultrasound densitometer unit. The White Plains, NY, company in June acquired rights to distribute and service an ultrasound bone measurement system developed by U.K. firm McCue.
The June 17 agreement gives Norland the right to distribute McCues CubaClinical system in Canada, parts of Europe, the Middle East, and the Pacific Rim. The company will distribute and service the system in the U.S. once it has received clearance from the Food and Drug Administration, which McCue expects later this year. CubaClinical is a dry system and boasts a large clinical database, according to Norland executives.
Norland signed a deal with IMRO in 1997 for rights to distribute IMROs existing ultrasound bone measurement system, which Norland called Paris (SCAN 2/18/98 and 9/17/97). Norland began shipping Paris to European and Pacific Rim clients last year, but when Paris didnt receive PMA clearance in the U.S. as Norland had expected, the company ended its alliance with IMRO.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.